|
Rationale:
- Because patients will likely have altered their meal times and be fasting before surgery, they should monitor their glucose
levels at home to ensure they are not low and be vigilant for early symptoms of hypoglycemia before and after surgery.
- Early identification of hypoglycemia allows for prompt treatment to halt progression.
- Because diabetic patients are at increased risk of having coronary artery disease, they need to be able to identify symptoms
of cardiac ischemia and to seek medical attention immediately.
- Determining details of outpatient therapy helps guide intraoperative diabetes management and allow for accurate resumption
of the patient's medication therapy in the postoperative phase.
- Early morning surgery, especially for procedures where the patient is expected to resume oral intake on the same day, minimizes
disruption in glucose reduction therapy and therefore glycemic control.
|
|
Evidence:
- In a case-control study of patients with deep sternal site infections after coronary artery bypass grafting, those with diabetes
with a preoperative glucose level >110 mg/dL had a higher risk of deep sternal wound infections (OR, 1.4 [CI, 0.4 to 4.8];
P=0.6) (8).
- A prospective cohort study of outpatients showed that low self-monitored blood glucose levels predicted severe episodes of
hypoglycemia (stupor or unconsciousness) among patients with type 1 diabetes (19).
- The American Diabetes Association published recommendations for glycemic goals for outpatients (35).
|
|
Comments:
|
| FAQs |
|
|
|
Melanie E. Mabrey, MSN, ACNP, BC-ADM has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Nadia A. Khan, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Susan E. Spratt, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
William A. Ghali, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Deborah Korenstein, MD, FACP, Co-Editor, PIER, has no financial relationships with pharmaceutical companies, biomedical device
manufacturers, or health-care related organizations. Richard B. Lynn, MD, FACP, Co-Editor, PIER, has no financial relationships
with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted © 2012 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|